Literature DB >> 11840511

Molecular analysis, mutation screening, and association study of adenylate cyclase type 9 gene (ADCY9) in mood disorders.

Tomoko Toyota1, Eiji Hattori, Joanne Meerabux, Kazuo Yamada, Koji Saito, Haruo Shibuya, Masahiro Nankai, Takeo Yoshikawa.   

Abstract

Chromosome 16p13 has been shown to display modest linkage signals for mood disorders in a number of studies. An interesting candidate gene in this region is the adenylate cyclase (AC) type 9 gene (ADCY9). ACs are critical in neuronal signaling, and perturbation of brain AC activity has been reported in mood disorder postmortem brains. ACs may also act as targets of antidepressants. Two distinct length transcripts for the ADCY9 gene have been reported, but molecular mechanisms are unknown. To investigate the potential role of ADCY9 in mood disorders, we clarified alternative poly(A) sites for the two mRNA species, delineated the exon-intron structure, and screened the gene for genetic variants. The two transcripts encoded by ADCY9 shared the first 10 exons, but exon 11 was shorter in one of the mRNA species. Seven single nucleotide polymorphisms, including a missense mutation and one polymorphic microsatellite repeat in the 3'-UTR, were identified. However, a case-control study using the missense polymorphism, 2316A>G (Ile772Met), and the tetranucleotide repeat (TTTA)n showed no significant association with mood disorders in Japanese samples. The DNA polymorphisms detected in this study can be tested in other ethnic samples and/or other psychiatric diseases. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840511     DOI: 10.1002/ajmg.10117

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

3.  No association between a polymorphism of the adenylate cyclase type IX gene and major depressive disorder in the Chinese Han population.

Authors:  Suxia Cao; Xiaofeng Zhao; Hengfen Li
Journal:  Neural Regen Res       Date:  2012-08-25       Impact factor: 5.135

4.  Loss of type 9 adenylyl cyclase triggers reduced phosphorylation of Hsp20 and diastolic dysfunction.

Authors:  Yong Li; Tanya A Baldwin; Yan Wang; Janani Subramaniam; Anibal Garza Carbajal; Cameron S Brand; Shane R Cunha; Carmen W Dessauer
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

Review 5.  Expression and functions of adenylyl cyclases in the CNS.

Authors:  Karan Devasani; Yao Yao
Journal:  Fluids Barriers CNS       Date:  2022-03-20

6.  Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.

Authors:  David Rhainds; Chris J Packard; Mathieu R Brodeur; Eric J Niesor; Frank M Sacks; J Wouter Jukema; R Scott Wright; David D Waters; Therese Heinonen; Donald M Black; Fouzia Laghrissi-Thode; Marie-Pierre Dubé; Marc A Pfeffer; Jean-Claude Tardif
Journal:  Circ Genom Precis Med       Date:  2021-04-02

7.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

8.  Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.

Authors:  Tobias O Apinjoh; Judith K Anchang-Kimbi; Clarisse Njua-Yafi; André N Ngwai; Regina N Mugri; Taane G Clark; Kirk A Rockett; Dominic P Kwiatkowski; Eric A Achidi
Journal:  Malar J       Date:  2014-06-16       Impact factor: 2.979

9.  Ulk4 regulates GABAergic signaling and anxiety-related behavior.

Authors:  Min Liu; Marie Fitzgibbon; Yanqin Wang; Jamie Reilly; Xiaohong Qian; Timothy O'Brien; Steve Clapcote; Sanbing Shen; Michelle Roche
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.